Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor plus standard induction chemotherapy in older patients with AML or high-risk MDS
NL-OMON25024Recruiting
- Sponsor
- HOVON
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of selinexor, sponsored by HOVON. Started Jul 2016; status: recruiting.
02
Drugs
selinexor
Beyond the preview
Go deeper on NL-OMON25024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25024.